Evidence map›Paper›PMID 42605596›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2026

Navigating Classical and Nonclassical Realms of Nucleation and Crystallization.

Stephan E Wolf, Peter G Vekilov

Abstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephan E WolfDepartment of Materials Science and Engineering, Institute for Glass and Ceramics, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID https://orcid.org/0000-0002-3747-8097
Peter G VekilovWilliam A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-3424-8720

Funding

Deutsche Forschungsgemeinschaft 501387034Deutsche Forschungsgemeinschaft 501391584Deutsche Forschungsgemeinschaft 554953245National Science Foundation DMR-2128121Welch Center for Advanced Bioactive Materials Crystallization V-E-0001Welch Foundation E-2170
6 · The paper itself

Abstract

Our understanding of the formation and growth of solids from solution has shaped science for centuries. The classical nucleation and crystal growth theories provided a foundational framework, despite their necessary simplifications. Recent nonclassical concepts have challenged this canon and refined the general models of the molecular and mesoscale processes underlying solid-state genesis. This shift of paradigms triggered novel terminology, often coined ad hoc to describe unexpected observations, but also created ambiguity across disciplinary boundaries. Here, we review current terminology, summarize the perceived classical canon, clarify ambiguous concepts, correct recurring misconceptions, and highlight terms that require further specification. We draw connections between colloidal, molecular, and mineral systems to develop generalizing concepts, while emphasizing where analogous phenomenology arises from distinct mechanistic or stabilizing conditions. We further identify the Szilard postulate-that crystallization proceeds by addition of individual ions or molecules-as a key criterion for distinguishing classical from nonclassical nucleation and growth mechanisms. By clarifying terminology and conceptual boundaries, this review provides a reference framework and a field guide for current debates on classical and nonclassical nucleation and crystallization.

Indexed as

crystal growthcrystallizationmesocrystalsnonclassicalnucleationterminology

Identifiers

PMID42605596
PMCPMC13548992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.